Michael Weisser, CEO of AiM (an IGES Group company), has been working at AiM for 16 years, providing consultancy services to industry. His focus is on market access and reimbursement of diagnostic and therapeutic procedures that are based on the use of medical devices, IVD and digital products. This involves setting up strategies and implementing them hands-on in the European and specifically German context